Kraken Robotics Inc (KRKNF): Kraken Robotics Receives $13 Million of...

Kraken Robotics Receives $13 Million of Subsea Battery Orders

PennyStaIker · 2024-10-16T17:20:13.6800000Z

Kraken Robotics Receives $13 Million of Subsea Battery Orders https://www.globenewswire.com/news-release/2024/10/16/2963876/0/en/Kraken-Robotics-Receives-13-Million-of-Subsea-Battery-Orders.html

Play Episode

5min

Proactive - Interviews for investors

North Bay Resources ships gold concentrate as mill optimization advances

North Bay Resources has reached a key milestone in its gold production efforts, successfully completing a test shipment of 327 lbs. of gold concentrate from the Bishop Gold Mill to Just Refiners in Reno, NV. CEO Jared Lazerson shared the update with Steve Darling from Proactive, emphasizing the company’s progress in optimizing mill operations and enhancing gold recovery from its Fran Gold Property. The February ore processing runs yielded approximately 2.44 troy ounces of contained gold from 10 tons of ore, equating to a recovered gold grade of 0.24 ounces per ton. Additionally, 0.1 ounces of contained gold remains in low-grade concentrate at the mill. Current estimates place overall recovery at 50%, with gravity-recoverable gold recovery at 70%. Metallurgical testing suggests that up to 67% gravity recovery can be achieved, with an additional 30% recoverable through flotation. To further enhance recovery rates, North Bay Resources is bringing its flotation circuit online, targeting very fine gold and gold in quartz that is not efficiently captured by existing gravity separation methods. This upgrade is expected to boost overall gold recovery by up to 30% as the company continues to refine its extraction process. With ongoing improvements to both its gravity and flotation circuits, North Bay Resources is poised to significantly enhance gold recovery and production efficiency at the Bishop Gold Mill, marking an important step in its broader operational strategy. #proactiveinvestors #northbayresourcesinc #otc #nbri #PlatinumConcentrate #NorthBayResources #MiningNews #CaliforniaGold #JaredLazerson #GoldRush #ProactiveInvestors #PreciousMetals #MiningUpdates ---#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Proactive - Interviews for investors

New Era Helium shifts focus to AI power needs with integrated energy strategy

New Era Helium CEO Will Gray joined Steve Darling from Proactive to outline the company’s strategic shift toward maximizing the value of its helium and natural gas assets in the Permian Basin to support the rapidly growing AI-driven economy. The company is positioning itself as a key player in behind-the-meter power generation, leveraging its resources to fuel high-performance computing and AI data centers. The company confirmed it remains on track to meet key production milestones while exploring an integrated energy strategy. Since 95% of the world’s helium is found in association with natural gas, the company sees a unique opportunity to directly contribute to the AI industry’s expanding power needs. Rather than selling natural gas as a commodity, New Era plans to utilize its Pecos Slope Gas Field to generate up to 70 megawatts (MW) of electricity for at least 20 years, supporting the rising demand for AI computing power. As part of this transition, the company’s joint venture, Texas Critical Data Centers, has signed a non-binding letter of intent to acquire land in Texas for a planned 250MW net-zero AI and high-performance computing center. This move aligns with increasing domestic demand for helium in semiconductor manufacturing and AI applications, further accelerated by the CHIPS and Science Act. New Era Helium anticipates providing a formal update on its Pecos Slope processing plant soon, signaling further progress in its energy-focused strategy. #proactiveinvestors #neweraheliuminc #nasdaq #nehc #oil #gas #perimianbasin #HeliumProduction #DataCenters #CarbonCapture #AI #Semiconductors #EnergyInnovation #NaturalGas #TechGrowth #SustainableEnergy

Proactive - Interviews for investors

Nextech3D.ai partners with CSM.ai to revolutionize scalable 3D model creation

Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce a strategic partnership with CSM.ai, a leading team of AI researchers, product innovators, and digital artists. This collaboration aims to advance the creation of high-quality, cost-efficient 3D models at scale, providing businesses with next-generation product visualization technology. Nextech3D.ai and CSM.ai began working together in early 2025, successfully delivering hundreds of 3D models to customers with faster turnaround times and reduced costs. The partnership enhances Nextech3D.ai’s automated 3D modeling pipeline while leveraging CSM.ai’s deep AI expertise. At the same time, CSM.ai benefits from Nextech3D.ai’s extensive experience in 3D e-commerce applications. By combining resources, the companies aim to further scale production, drive down costs, and unlock new opportunities in the evolving 3D visualization industry, delivering substantial value to businesses and consumers alike. #nextech3d.al #otcqx #nexcf #cse #ntar #EvanGappelberg #AmazonSellerCentral #3DModeling #AIPhotography #EcommerceInnovation #3DTechnology #LifestylePhotography #ProactiveInterviews #TechInnovation #AmazonPartners#proactiveinvestors #nextech3d.al

Proactive - Interviews for investors

Clinical study SKNJCT-003 shows positive trends as company advances skin cancer research in UAE

Medicus Pharma CEO Dr. Raza Bokhari joined Steve Darling from Proactive to share updates on the ongoing SKNJCT-003 clinical study, which is being conducted at nine sites across the United States and aims to randomize 60 patients. An interim analysis conducted after enrolling more than half of the targeted participants has shown encouraging results. The study reports a clinical clearance rate exceeding 60%, with the investigational therapy demonstrating strong tolerability across both tested dosage levels. Notably, no dose-limiting toxicities (DLTs) or serious adverse events (SAEs) have been observed, and there have been no systemic effects or clinically significant abnormalities in laboratory results, ECGs, vital signs, or physical exams. These promising findings will be submitted to the U.S. Food and Drug Administration (FDA) as part of a Type C meeting request in Q2 2025. In parallel, the company is advancing its clinical initiatives for non-invasive basal cell carcinoma treatment with a newly proposed study. This randomized, double-blind, placebo-controlled, multi-center trial has been submitted for approval to the UAE Department of Health. The study aims to enroll up to 36 patients at prominent medical institutions, including Cleveland Clinic Abu Dhabi, Sheikh Shakbout Medical City, Burjeel Medical City, and the American Hospital of Dubai. Participants will be assigned in a 1:1:1 ratio to receive either a placebo or one of two dosage levels of the experimental treatment. This expansion into the UAE represents a significant step forward in the company’s mission to develop innovative, non-invasive therapies for skin cancer, broadening its global clinical footprint and reinforcing its commitment to advancing patient care. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #Biotech #CancerTreatment #ClinicalTrials #FDAApproval #SkinCancer #HealthcareInnovation #Investing #MedicalResearch

Followers	15
Posts	452
Boards Moderated	0
Alias Born	02/14/2021

Volume:	360,581
Day Range:	1.54 - 1.65
Bid:	0.01
Ask:	25.66
Last Trade Time:	4:49:29 PM EDT
Total Trades:	325

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

KRKNF Detailed Quote

Recent KRKNF News

More KRKNF News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent KRKNF News

Go Ad-Free